Clinical Study of Tripterygium Capsule to Treat Early Ankylosing Spondylitis

Summary

This study is a 12-week, randomized, placebo and positive drug controlled clinical trial to investigate whether tripterygium capsule is effective and safe in treating patients with ankylosing spondylitis. The investigators expect that the tripterygium capsule is more effective than placebo and has few adverse effects.

Timeline

Start

2008-10

Primary completion

2009-07

Completion

2009-08

Drugs

Indications